← Back to Search

Behavioral Intervention

Gamification for Medication Adherence in High Blood Pressure and Cholesterol

N/A

Waitlist Available

Led By Alexander Fanaroff, MD, MHS

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Prescribed 1 or 2 blood pressure medications and a statin medication for > 1 year

Has supply of medications at the time of enrollment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 weeks (during study weeks 14-18)

Awards & highlights

Study Summary

This trial will study whether a gamification intervention can increase medication adherence in patients with hypertension and hyperlipidemia. The intervention will include social support and accountability measures.

Who is the study for?

This trial is for patients with high blood pressure and cholesterol who have struggled to take their medications regularly. They must own a smartphone, have had a recent blood pressure reading over 140 mm Hg, been on specific meds for over a year, and not taken them as prescribed in the last 6 months. Those with very high blood pressure or less than 6 months to live cannot join.Check my eligibility

What is being tested?

The study tests if adding game-like elements (gamification) to treatment, along with support from friends or family and reporting to doctors can help patients stick to their medication schedules better than just getting reminder texts.See study design

What are the potential side effects?

Since this trial focuses on improving medication adherence through gamification rather than testing new drugs, side effects are minimal and may include frustration or stress related to the use of technology or game mechanics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been on 1 or 2 blood pressure meds and a statin for over a year.

Select...

I have my medications available now.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks (during study weeks 14-18)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks (during study weeks 14-18)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks (during study weeks 14-18) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

patient-reported adherence

Secondary outcome measures

Change in blood pressure over study duration

Medication possession ratio in weeks 14-18

Medication possession ratio over study duration

+1 more

Other outcome measures

Change in low density lipoprotein cholesterol

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Via the Way to Health platform, all patients will receive daily text messages asking about medication adherence for that day and twice weekly text messages asking if participants have measured blood pressure on that day. Participants are entered into a game. Each week they receive 90 points. If they took their medications or checked their blood pressure the prior day, they keep their points, but if not, they lose 10 points. At the end of the week if they have at least 70 points they move up a level, but if not, they drop a level. Participants start in the middle of 5 levels. Participants choose a support partner. At the start of the intervention, the study team holds a 3-way phone call with the participant and support partner to discuss ways they can help the participant meet their goal. The support partner gets a weekly email with the participant's progress. Primary care physicians will receive a monthly email noting patients' self-reported adherence and blood pressure.

Group II: ControlActive Control1 Intervention

Via the Way to Health platform, all participants will receive daily text messages asking about medication adherence for that day and twice weekly text messages asking if participants have measured blood pressure on that day.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,009 Previous Clinical Trials

42,894,569 Total Patients Enrolled

Alexander Fanaroff, MD, MHSPrincipal InvestigatorUniversity of Pennsylvania

5 Previous Clinical Trials

4,352 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being recruited for participation in this experiment?

"Affirmative. According to clinicaltrials.gov, this experimental intervention is actively enrolling patients that meet the criteria for participation. The study was originally posted on September 12th 2022 and received its last update a fortnight later on September 27th 2022. There are 84 positions which need to be filled from 1 medical facility."

Answered by AI

Is there still opportunity to partake in this research study?

"According to clinicaltrials.gov, this campaign of patient recruitment is ongoing. It was first launched on September 12th 2022 and has been amended since then."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Gamification and Medication Adherence (GAME Adherence)

2022. "Gamification and Medication Adherence (GAME Adherence)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05326386.